A novel record-linkage approach is applied to examine the incidence of HCV reinfection.
More frequent HCV RNA testing post SVR is required to identify HCV reinfections in a timely manner.
HCV reinfection among PWID, on the whole, is low.
Reinfection should not be seen as a barrier to treating PWID with antiviral therapy.